Spotlight on Annals

Hopefully you have received your February issue of the Annals of Allergy, Asthma and Immunology and have read and benefitted from its contents. But, just in case you have not yet had a chance to read in detail or if you happened to miss these, I want to call to more articles to your attention for you to read that should be able to help you in your practice.

The February issue of the Annals of Allergy, Asthma and Immunology has a special emphasis on the atopic march. From the cover that depicts a typical march from dermatitis through food allergy to asthma and rhinitis, this is a message that bears repeating by all of us to researchers, patients and their families, payers and society at large. This concept has enjoyed  a “practical home” with the practicing allergist-immunologist as we increasingly incorporate prevention strategies into our daily practices.

Hopefully all of you have received the January issue of the Annals of Allergy, Asthma and Immunology and have seen the many great features and articles contained in our pages. I want to point out two articles that I hope many of you have already read but, if not, that you will take the time to do so. They should definitively be useful to you in your practice.

The January 2018 issue of the Annals of Allergy, Asthma and Immunology launches the renewed effort of our journal to serve our readers with the highest possible quality publication features. We have a great new team of editors and support staff who are working very hard to make our journal greater than it ever has been. Of course, the final metric is the quality of the material we publish and its utility to you. In that regard, we have many features that offer “something for everyone” in this issue. Two such manuscripts deserve special mention.

As 2017 draws to a close, I want to thank all of the people who make the Annals of Allergy, Asthma and Immunology a successful journal. Our editors, editorial staff and publisher all play integral roles for our journal. But it is you, our readers, that make the efforts to provide a scientific journal for the practicing clinician worthwhile. With these thoughts in mind, I would like to call your attention to two more articles in our Dec. issue that may be useful for you in your practice – both now and in the future.

While the December 2017 Annals of Allergy, Asthma and Immunology is the final issue of the year, it has some great articles for the practicing clinician. These articles will increase your knowledge base as well as provide guidance for various aspects of patient care. Two articles in particular meet these important metrics.

There are two additional special articles that I call your attention to in the November issue of the Annals of Allergy, Asthma and Immunology that should be of benefit to you in the care of your patients. The first, authored by Megan Motosue, MD, and colleagues, examine the likelihood of patients admitted to the Emergency Department (ED) for episodes of anaphylaxis to be prescribed an epi-pen and referred to an allergy-immunology specialist for follow up.

The November issue of the Annals of Allergy, Asthma and Immunology has a variety of features for our practicing clinician readers. There are features and information about many aspects of our specialty. There are two articles in particular that are worth mentioning.

As the month of October winds down, hopefully everyone has had an opportunity to read and utilize the information from the many articles in this month’s Annals of Allergy, Asthma and Immunology. I want to call to attention to two articles that are of very pragmatic value for practicing clinicians.

The October issue of the Annals of Allergy, Asthma and Immunology has many articles and features that should be of interest to our readers. We have published on a wide variety that will impact practice.

One such article is written by Mark Ballow, MD, FACAAI, and provides an excellent evidence-based overview of the pragmatic aspects of immunoglobulin replacement. He traces the history of immunoglobulin replacement technology from intramuscular injections to current subcutaneous therapy, and the evolution of dosing strategies including amount and frequency. This is all accomplished using a clinical case and is a must read for all who engage in Ig replacement.